{"key":"tesamorelin","slug":"tesamorelin","name":"Tesamorelin","other_names":["TH9507","TH-9507","Tesamorelin acetate"],"kind":"single","area":{"slug":"gh-axis","name":"GH axis"},"classification":"Stabilized GHRH analogue","standing":{"id":"approved","label":"Licensed medicine","rank":5},"summary":"A stabilized analogue of growth hormone releasing hormone, licensed in the United States to reduce excess abdominal fat in people with HIV and lipodystrophy.","cas_number":"218949-48-5","molecular_formula":"C221H366N72O67S","molecular_weight":"5135.8 g/mol","components":[],"has_article":false,"pubmed":{"papers":97,"in_humans":76,"clinical_trials":23},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/tesamorelin","article":null,"evidence":{"query":"(\"Tesamorelin\"[tiab])","fetched_at":"2026-11-16T23:08:08.948Z","counts":{"rcts":21,"human":76,"total":97,"reviews":34,"clinicalTrials":23},"years":[{"year":2012,"count":8},{"year":2013,"count":5},{"year":2014,"count":2},{"year":2015,"count":4},{"year":2016,"count":5},{"year":2017,"count":5},{"year":2018,"count":1},{"year":2019,"count":5},{"year":2020,"count":3},{"year":2021,"count":6},{"year":2022,"count":5},{"year":2023,"count":2},{"year":2024,"count":4},{"year":2025,"count":4},{"year":2026,"count":17}],"top":[{"doi":"10.1172/jci.insight.140134","url":"https://pubmed.ncbi.nlm.nih.gov/32701508/","kind":"rct","pmid":"32701508","year":2020,"title":"Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD","venue":"JCI insight","authors":"Fourman LT, Billingsley JM, Agyapong G, et al."},{"doi":"10.1097/QAD.0000000000003965","url":"https://pubmed.ncbi.nlm.nih.gov/38905488/","kind":"rct","pmid":"38905488","year":2024,"title":"Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors","venue":"AIDS (London, England)","authors":"Russo SC, Ockene MW, Arpante AK, et al."},{"doi":"10.1016/j.ghir.2017.10.002","url":"https://pubmed.ncbi.nlm.nih.gov/29031905/","kind":"rct","pmid":"29031905","year":2017,"title":"Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation","venue":"Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society","authors":"Braun LR, Feldpausch MN, Czerwonka N, et al."},{"doi":"10.1093/infdis/jiaf012","url":"https://pubmed.ncbi.nlm.nih.gov/39813152/","kind":"rct","pmid":"39813152","year":2025,"title":"Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity","venue":"The Journal of infectious diseases","authors":"Ellis RJ, Vaida F, Hu K, et al."},{"doi":"10.1210/jc.2013-3436","url":"https://pubmed.ncbi.nlm.nih.gov/24178787/","kind":"rct","pmid":"24178787","year":2014,"title":"The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH","venue":"The Journal of clinical endocrinology and metabolism","authors":"Makimura H, Murphy CA, Feldpausch MN, et al."},{"doi":"10.1016/j.orcp.2026.01.002","url":"https://pubmed.ncbi.nlm.nih.gov/41545261/","kind":"meta","pmid":"41545261","year":2026,"title":"Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials","venue":"Obesity research & clinical practice","authors":"Badran AS, Helal A, Shata KS, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/31644039/","kind":"review","pmid":"31644039","year":2012,"title":"Tesamorelin","venue":"","authors":""},{"doi":"10.1038/nrd3362","url":"https://pubmed.ncbi.nlm.nih.gov/21283099/","kind":"study","pmid":"21283099","year":2011,"title":"Tesamorelin","venue":"Nature reviews. Drug discovery","authors":"Grunfeld C, Dritselis A, Kirkpatrick P"},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/21591600/","kind":"study","pmid":"21591600","year":2010,"title":"Tesamorelin update","venue":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","authors":"O'Neal R"},{"doi":"10.1038/s41598-021-89966-y","url":"https://pubmed.ncbi.nlm.nih.gov/34006921/","kind":"study","pmid":"34006921","year":2021,"title":"Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach","venue":"Scientific reports","authors":"Fourman LT, Stanley TL, Billingsley JM, et al."}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}